Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-08 07:05:00 ET AMLX

Published on 05/08/2025 at 07:05, updated on 05/08/2025 at 10:40

Amylyx Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 35.91 million compared to USD 118.79 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 1.75 a year ago.

Diluted loss per share from continuing operations was USD 0.42 compared to USD 1.75 a year ago.